10-Q: Viemed Healthcare Reports Strong Revenue Growth in Q3 2024, Driven by Ventilator Rentals and Service Expansion

Sentiment:

Quarterly Report


Viemed Healthcare saw a 17.4% increase in revenue in the third quarter of 2024, primarily driven by growth in ventilator rentals and healthcare staffing services.

Delay expectedThe company experienced delays in submitting patient claims due to a cybersecurity incident at Change Healthcare, which temporarily reduced operating cash flow and increased accounts receivable.
Better than expectedThe company's revenue growth of 17.4% in Q3 2024 exceeded expectations.Net income increased by 33.8% in Q3 2024, indicating better than expected profitability.The company's service revenue growth of 140.3% in Q3 2024 was significantly higher than anticipated.

Summary

  • Viemed Healthcare's revenue for the third quarter of 2024 reached $58 million, a 17.4% increase compared to the same period in 2023.
  • The company's ventilator rental revenue grew by 12.2%, while service revenue increased significantly by 140.3% due to the expansion of healthcare staffing services.
  • Other home medical equipment rentals also contributed to the growth, increasing by 12.1%, and equipment and supply sales rose by 9.0%.
  • Gross profit for the quarter was $34.4 million, with a gross profit margin of 59.3%, slightly lower than the 61.9% reported in the same quarter of the previous year.
  • Net income for the quarter was $3.9 million, a 33.8% increase compared to the $2.9 million reported in the third quarter of 2023.
  • The company's operating expenses increased, with selling, general, and administrative expenses rising by 12.8% to $26.7 million.
  • Viemed's research and development expenses increased by 27.7% to $0.8 million.
  • Stock-based compensation expenses also increased by 17.8% to $1.7 million.
  • The company reported a gain on disposal of property and equipment of $0.5 million, compared to a loss of $0.3 million in the same period last year.
  • For the nine months ended September 30, 2024, revenue totaled $163.6 million, a 23.7% increase compared to the same period in 2023.
  • Net income for the nine months ended September 30, 2024 was $7.0 million, a 3.2% increase compared to the same period in 2023.

Sentiment

Score: 8

Explanation: The document shows strong revenue growth and improved profitability, indicating a positive outlook. However, there are some concerns about decreasing gross profit margins and non-operating impairments, which temper the overall sentiment.

Positives

  • Viemed experienced strong revenue growth across multiple segments, including ventilator rentals, other HME rentals, and service revenues.
  • The company's net income increased significantly in Q3 2024, indicating improved profitability.
  • Viemed's healthcare staffing services are showing strong growth, diversifying the company's revenue streams.
  • The company is seeing gains from the disposal of recalled ventilators.
  • The company is managing selling, general and administrative expenses effectively, improving as a percentage of revenue.

Negatives

  • Gross profit margin decreased slightly in Q3 2024 compared to the same period in 2023.
  • The company experienced an impairment loss on its debt investment, impacting non-operating income.
  • The company experienced an impairment of a litigation receivable due to a counterparty's bankruptcy proceedings.
  • The company's net income as a percentage of revenue decreased for the nine months ended September 30, 2024, primarily due to non-operating fair value impairments.

Risks

  • The company faces potential inflationary pressures that could impact manufacturing and distribution costs.
  • The company is subject to fluctuations in interest rates on its borrowings.
  • The company is exposed to risks associated with governmental investigations, audits, and reviews.
  • The company is subject to the risk of potential legal actions and other proceedings.
  • The company is subject to the risk of cybersecurity incidents.

Future Outlook

The company expects continued growth in its active ventilator patient base and other respiratory offerings as it expands geographically. They also anticipate that selling, general and administrative expenses as a percentage of revenue will remain stable through the end of 2024 due to increased efficiencies and costs optimization efforts relative to revenue growth. The company expects a reduction in quarterly net interest expense for the remainder of 2024 due to continued repayments on debt.

Management Comments

  • Management believes Adjusted EBITDA provides helpful information with respect to the Company's operating performance.
  • Management uses Adjusted EBITDA to compare the Company's operating performance on a consistent basis, to calculate incentive compensation for the Company's employees, for planning purposes, and to evaluate the performance and effectiveness of the Company's operational strategies.

Industry Context

The home medical equipment market is experiencing sustained expansion, particularly in the complex respiratory and OSA device segments. The aging population and the rising incidence of chronic diseases are driving demand for home-based treatments. The industry is also transitioning to value-based healthcare, which favors providers like Viemed. Market consolidation is also a trend that favors larger, financially stable players.

Comparison to Industry Standards

  • The industry is experiencing a Compound Annual Growth Rate (CAGR) of approximately 6% for respiratory devices and 8% for OSA devices, which Viemed's growth appears to be exceeding.
  • U.S. home healthcare spending is projected to reach $250 billion by 2031, with a CAGR of approximately 7%, indicating a strong market for Viemed's services.
  • The company's focus on home-based treatment aligns with the industry's shift towards value-based healthcare, which is a positive trend.
  • The company's expansion into new territories and its focus on cost-efficient operations are consistent with the strategies of successful players in the consolidated DME market.

Legal Proceedings

  • The company is involved in a lawsuit against Vyaire Medical, Inc., where a partial summary judgment was granted in the company's favor, however, collection of the claim is not probable due to Vyaire's bankruptcy.
  • The company is subject to various external governmental investigations, audits, and reviews.

Stakeholder Impact

  • Shareholders will benefit from the company's strong revenue growth and improved profitability.
  • Employees will benefit from the company's growth and expansion, as well as stock-based compensation.
  • Customers will benefit from the company's continued focus on providing high-quality home medical equipment and services.
  • Suppliers may benefit from the company's increased purchasing power and volume.

Next Steps

  • The company plans to continue expanding its service areas and launching in new territories.
  • The company intends to continue employing more Respiratory Therapists to maintain its high service model.
  • The company will continue to invest in research and development related projects to support its technology initiatives.

Key Dates

DateDescription
2016-12-14Viemed Healthcare, Inc. was incorporated under the Business Corporations Act (British Columbia).
2020-06-11Effective date of the 2020 Long Term Incentive Plan.
2022-11-29The company refinanced its existing borrowings and entered into the 2022 Senior Credit Facilities.
2023-06-01Viemed acquired Home Medical Products, Inc.
2024-04-01Viemed acquired a controlling interest in East Alabama HomeMed, LLC.
2024-05-28The company entered into a First Amendment to the 2022 Senior Credit Facilities.
2024-06-06Shareholders approved the company's 2024 Long Term Incentive Plan.
2024-09-30End of the quarterly period covered by this report.
2024-10-28Date as of which there were 38,936,562 common shares of the registrant outstanding.
2024-11-06Date of the filing of this report.
2024-12-31The company will no longer qualify as an emerging growth company.

Keywords

Viemed Healthcare, home medical equipment, respiratory care, ventilator rentals, healthcare staffing, revenue growth, net income, gross profit, HME, medical equipment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.